Arrowhead Pharmaceuticals Inc. (ARWR) Misses Q3 EPS by 9c
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $81.82 +0.96%
Revenue Growth %: +89.5%
Financial Fact:
Loss on sale of fixed assets, net: 0
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: +89.5%
Financial Fact:
Loss on sale of fixed assets, net: 0
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q3 EPS of ($0.29), $0.09 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $45.89 million versus the consensus estimate of $37.52 million.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Air France-KLM (AF:FP) (AFLYY) PT Raised to EUR13.50 at UBS
- Wall Street scrambles to lift Micron price targets ahead of earnings
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
